Ironwood gets U.S. rights to AZ's Zurampic

AstraZeneca plc (LSE:AZN; NYSE:AZN) granted Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) exclusive, U.S. rights to Zurampic lesinurad, which

Read the full 164 word article

User Sign In